Heterogeneous Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes: A Causal Forest and Target Trial Emulation Study

By afschroeder • September 2, 2025

Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kawakami K, Kondo N, Tsugawa Y, Yabe D, Yanagita M, Inoue K. Heterogeneous Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes: A Causal Forest and Target Trial Emulation Study. Eur J Prev Cardiol. 2025 Sep 1:zwaf539. doi: 10.1093/eurjpc/zwaf539. Epub ahead of print. PMID: 40889271.

Tags: General Internal Medicine, Publications

Ambient AI Scribes in Clinical Practice: A Randomized Trial

Lukac PJ, Turner W, Vangala S, Chin AT, Khalili J, Shih YT, Sarkisian C, Cheng EM, Mafi JN. Ambient AI Scribes in Clinical Practice: A[...]

North American and European practices for opioid-sparing and opioid-free anaesthesia: a cross-sectional survey

Gricourt Y, Boulos NM, Daoulas Y, Grogan T, Alexander B, Mezzarobba M, Cuvillon P, Pogatzki-Zahn EM, Beloeil H, Cannesson M, Forget P, Joosten A. North[...]

Primary Care Providers’ Perspectives on Barriers and Facilitators to Human Papillomavirus (HPV) Vaccination among Young Adults: A Qualitative Study

Vázquez-Otero C, Owens HN, Arevalo M, Cui J, Chavez MN, Maconi ML, Geiss C, Turner K, Vadaparampil ST, Barrios-Monroy V, Pena A, Whiting J, Christy[...]